Results 61 to 70 of about 14,435 (170)

Pulmonary Herpes Simplex Virus Reactivation in Invasively Mechanically Ventilated Patients With COVID‐19 in Intensive Care Unit

Journal of Medical Virology, Volume 98, Issue 10, October 2026.
ABSTRACT Patients in intensive care units (ICU) under mechanical ventilation, particularly those with SARS‐CoV‐2 infection, are highly susceptible to Herpes simplex virus (HSV) reactivation. Given the lack of data on the SARS‐CoV‐2 Omicron and Delta variants, this study aimed to assess the prevalence of pulmonary HSV reactivation in mechanically ...
Bastien Zarlenga, Florent Wallet, Alexandre Gaymard, Anne‐Claire Lukaszewicz, Gregory Destras, Christophe Ginevra, Bruno Simon, Jennifer Giorgi, Muriel Rabilloud, Salomé Avenas, Alexis Trecourt, Geneviève Billaud, Florence Morfin, Jean‐Christophe Richard, Emilie Frobert   +14 more
wiley   +1 more source

Nirmatrelvir-ritonavir for COVID-19 [PDF]

Canadian Medical Association Journal, 2022
McDonald, Emily G, Lee, Todd C
openaire   +2 more sources

Ursodeoxycholic Acid Reduces Angiotensin‐Converting Enzyme 2 Activity and Suppresses Cytokine Storm Syndrome in Patients With Coronavirus Disease 2019

MedComm, Volume 7, Issue 9, September 2026.
SARS‐CoV‐2 infection causes COVID‐19 and stimulates immune cells, such as dendritic cells, monocytes, and macrophages, to increase levels of many cytokines. Ursodeoxycholic acid (UDCA) inhibits farnesoid X receptor (FXR), resulting in a decrease in the activity of angiotensin‐converting enzyme 2 (ACE2), the main receptor on the membrane for SARS‐CoV‐2.
Zhaowei Tong, Jiawei Zhu, Jianfeng Zhong, Qi Wang, Fuchu Qian, Lili Zhao, Weihong Wang, Yuepao Cai, Kefeng Qin   +8 more
wiley   +1 more source

Image_1_Can nirmatrelvir/ritonavir treatment shorten the duration of COVID-19 isolation?.pdf

, 2022
BackgroundThe impact of nirmatrelvir/ritonavir treatment on shedding of viable virus in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is unclear.MethodsA prospective cohort study evaluating mildly ill COVID-19 patients was conducted ...
Doo Ryeon Chung (7207214), Haein Kim (4839594), Joo-Yeon Lee (8816642), Young Ho Lee (7851581), Sun Young Cho (8768878), Byoung Kwon Park (6740516), Kyungmin Huh (5636111), Kyong Ran Peck (8768880), Jae-Hoon Ko (6800930), Yoo Jin Na (4002788), Jung-Min Lee (546902), Jeong-Sun Yang (4856530), Sehee Park (521956), Hyungjin Kim (582645), Jinyoung Yang (1692094), Myungsun Lee (384428), Younmin Shin (13945449), Jun-Won Kim (13407875), Cheol-In Kang (6800951)   +18 more
core   +1 more source

Complete Heart Block Triggered by Nirmatrelvir-Ritonavir and Verapamil. [PDF]

JACC Case Rep
Ritonavir-boosted nirmatrelvir (Paxlovid) is a treatment for COVID-19. However, ritonavir, a cytochrome P450 (CYP) CYP3A4 inhibitor, poses a risk of significant drug-drug interactions.
Offord E, Nabi M, Mankbadi M, Marchetta A, Rosenthal L.   +4 more
europepmc   +2 more sources

Evaluation of a Protocol Managing the Cyclosporine and Nirmatrelvir/Ritonavir Interaction in Kidney Transplant Recipients. [PDF]

Kidney360
Pharmacy residents have the opportunity to complete a research project during their residency training, which provides them with skills on how to conduct and manage a research project.
Agtarap K, Giguère P, Deschênes MJ, DeVreese L, McDougall J, Hoar S, Hiremath S.   +6 more
europepmc   +3 more sources

Effect of Paxlovid in COVID-19 treatment during the periods of SARS-CoV-2 Omicron BA.5 and BN.1 subvariant dominance in the Republic of Korea: a retrospective cohort study [PDF]

Osong Public Health and Research Perspectives
Objectives This study was conducted to assess the efficacy of nirmatrelvir/ritonavir treatment in patients with coronavirus disease 2019 (COVID-19), particularly those aged 60 years and older.
Dong-Hwi Kim, Min-Gyu Yoo, Na-Young Kim, So Young Choi, Minjeong Jang, Misuk An, Se-Jin Jeong, Jungyeon Kim   +7 more
doaj   +1 more source

Reply to the Letter by Mazzitelli M. et al. Regarding “Impact of COVID‐19 on Hematologic Cancer Patients: Insights From the Late Pandemic Phase”

Cancer Medicine, Volume 15, Issue 10, October 2026.
Daniele Caracciolo, Pierfrancesco Tassone, Pierosandro Tagliaferri   +2 more
wiley   +1 more source

Thai Transplant Care Practice Guideline on Immunosuppressive Therapy for Adult Kidney Transplantation

Nephrology, Volume 31, Issue S2, September 2026.
ABSTRACT The Thai Transplantation Society developed these clinical practice guidelines to establish a comprehensive standard for immunosuppressive therapy in adult kidney transplantation. While rooted in evidence‐based medicine, the objective of this document extends beyond local application, serving as a practical model for low‐to‐middle‐income ...
Suwasin Udomkarnjananun, Napun Sutharattanapong, Nuttasith Larpparisuth, Korntip Phonphok, Tanun Ngamvichchukorn, Peenida Skulratanasak, Pitchamon Inkong, Suwikran Wongpraphairot, Opas Traitanon, Piyavadee Homkrailas, Kajohnsak Noppakun, Natavudh Townamchai, on behalf of Thai Transplantation Society   +12 more
wiley   +1 more source

Drug-related problems and challenges encountered by pharmacists in nirmatrelvir/ritonavir counselling during the covid-19 pandemic: a multi-center study

Scientific Reports
Pharmacists’ counselling roles expanded significantly during the COVID-19 pandemic, yet drug-related problems (DRPs) and challenges during nirmatrelvir/ritonavir counselling remain underreported.
Shamala Balan, Kavidha Mohan, Vanitha Hong Wee Liang, Hanis Hazwanie Ghazali, Chew Li Suan, Chong Chia Chee, Kong Wei En, Leana Fatimah Makhdzir, Nurul Syafiqah Samsuri, Nor Mazni Mohamad Tamyes, Juliana Nazlim Lim, Nur Amirah Mohd Noor Azami, Suhaili Samad, Kiren Kaur Chut Singh, Nurfareeza Nazir Khan, Siti Hajar Chamati, Nurdiana Hassan, Kuay Hue Ping, Farraha Nordin, Lau Wai Hoong, Azlen Awatif Abu Bakar   +20 more
doaj   +1 more source